SF Williams

819 total citations
12 papers, 627 citations indexed

About

SF Williams is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, SF Williams has authored 12 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in SF Williams's work include Hematopoietic Stem Cell Transplantation (7 papers), Neutropenia and Cancer Infections (5 papers) and Acute Myeloid Leukemia Research (3 papers). SF Williams is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Neutropenia and Cancer Infections (5 papers) and Acute Myeloid Leukemia Research (3 papers). SF Williams collaborates with scholars based in United States. SF Williams's co-authors include MA Bitter, MM Le Beau, Richard A. Larson, JD Rowley, JW Vardiman, SL Smith, Jafar Al‐Sadir, JG Bender, M Schilling and D. Van Epps and has published in prestigious journals such as Blood, Gene Therapy and Bone Marrow Transplantation.

In The Last Decade

SF Williams

12 papers receiving 607 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SF Williams United States 10 447 164 157 102 99 12 627
A. Kabral Australia 13 443 1.0× 73 0.4× 119 0.8× 76 0.7× 135 1.4× 26 610
P Buchinger Austria 13 411 0.9× 136 0.8× 124 0.8× 81 0.8× 127 1.3× 22 632
F. M. Fink Austria 11 190 0.4× 68 0.4× 125 0.8× 60 0.6× 73 0.7× 21 439
Uri Mintz Israel 14 286 0.6× 139 0.8× 127 0.8× 194 1.9× 140 1.4× 34 695
J Odriozola Spain 15 667 1.5× 192 1.2× 261 1.7× 269 2.6× 121 1.2× 46 914
Emel Bayar United States 6 310 0.7× 87 0.5× 611 3.9× 68 0.7× 144 1.5× 8 796
Phillips Gl Canada 11 363 0.8× 109 0.7× 74 0.5× 123 1.2× 58 0.6× 19 475
Silvana Capalbo Italy 15 289 0.6× 166 1.0× 144 0.9× 271 2.7× 46 0.5× 37 669
A. R. Zander Germany 8 332 0.7× 137 0.8× 102 0.6× 176 1.7× 102 1.0× 16 555
Yuji Miyajima Japan 14 181 0.4× 75 0.5× 132 0.8× 77 0.8× 22 0.2× 29 592

Countries citing papers authored by SF Williams

Since Specialization
Citations

This map shows the geographic impact of SF Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SF Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SF Williams more than expected).

Fields of papers citing papers by SF Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SF Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SF Williams. The network helps show where SF Williams may publish in the future.

Co-authorship network of co-authors of SF Williams

This figure shows the co-authorship network connecting the top 25 collaborators of SF Williams. A scholar is included among the top collaborators of SF Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SF Williams. SF Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Waggoner, Steven, et al.. (2001). A phase II trial of docetaxel for peripheral blood stem cell mobilization for patients with breast cancer and ovarian cancer. Bone Marrow Transplantation. 27(7). 677–681. 5 indexed citations
2.
Smith, SL, et al.. (2001). Efficient expression of foreign genes in human CD34+ hematopoietic precursor cells using electroporation. Gene Therapy. 8(5). 384–390. 21 indexed citations
3.
Williams, SF, et al.. (2001). Optimization of culture conditions to enhance transfection of human CD34+ cells by electroporation. Bone Marrow Transplantation. 27(11). 1201–1209. 18 indexed citations
4.
Al‐Sadir, Jafar, et al.. (2000). Cardiac and pulmonary toxicity in patients undergoing high-dose chemotherapy for lymphoma and breast cancer: prognostic factors. Bone Marrow Transplantation. 25(8). 885–894. 68 indexed citations
5.
Bender, JG, et al.. (2000). Clinical impact of ex vivo differentiated myeloid precursors after high-dose chemotherapy and peripheral blood progenitor cell rescue. Bone Marrow Transplantation. 26(5). 505–510. 18 indexed citations
6.
Beau, MM Le, et al.. (1999). Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation. Bone Marrow Transplantation. 23(11). 1161–1165. 41 indexed citations
7.
8.
Jd, Bitran, et al.. (1998). High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience. Bone Marrow Transplantation. 21(2). 127–132. 26 indexed citations
9.
Williams, SF, JG Bender, M Schilling, et al.. (1996). Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood. 87(5). 1687–1691. 152 indexed citations
10.
Williams, SF, Wen‐Jeng Lee, JG Bender, et al.. (1996). Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood. 87(5). 1687–1691. 10 indexed citations
11.
Larson, Richard A., SF Williams, MM Le Beau, et al.. (1986). Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood. 68(6). 1242–1249. 8 indexed citations
12.
Larson, Richard A., SF Williams, MM Le Beau, et al.. (1986). Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16;16) has a favorable prognosis. Blood. 68(6). 1242–1249. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Kabral Breakdown of academic impact, for papers by P Buchinger Breakdown of academic impact, for papers by F. M. Fink Breakdown of academic impact, for papers by Uri Mintz Breakdown of academic impact, for papers by J Odriozola Breakdown of academic impact, for papers by Emel Bayar Breakdown of academic impact, for papers by Phillips Gl Breakdown of academic impact, for papers by Silvana Capalbo Breakdown of academic impact, for papers by A. R. Zander Breakdown of academic impact, for papers by Yuji Miyajima
Rankless by CCL
2026